These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37264723)

  • 1. Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease.
    Otaki Y; Watanabe T; Shimizu M; Tachibana S; Sato J; Kobayashi Y; Saito Y; Aono T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
    ESC Heart Fail; 2023 Aug; 10(4):2458-2468. PubMed ID: 37264723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Takahashi H; Funayama A; Kinoshita D; Yokoyama M; Takahashi T; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
    Clin Res Cardiol; 2016 Feb; 105(2):162-71. PubMed ID: 26220048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypokalemia, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Otaki Y; Watanabe T; Yamaguchi R; Tachibana S; Sato J; Kato S; Tamura H; Nishiyama S; Arimoto T; Takahashi H; Watanabe M
    Circ J; 2023 Dec; 88(1):117-126. PubMed ID: 37981326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease.
    Bansal N; Zelnick LR; Scherzer R; Estrella M; Shlipak MG
    Circ Heart Fail; 2024 May; 17(5):e011173. PubMed ID: 38742428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
    Otaki Y; Watanabe T; Takahashi H; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
    Int J Cardiol; 2014 May; 173(2):222-8. PubMed ID: 24630338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.
    Nayor M; Larson MG; Wang N; Santhanakrishnan R; Lee DS; Tsao CW; Cheng S; Benjamin EJ; Vasan RS; Levy D; Fox CS; Ho JE
    Eur J Heart Fail; 2017 May; 19(5):615-623. PubMed ID: 28217978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of renal tubular damage, as assessed by urinary β2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Shishido T; Takahashi H; Funayama A; Narumi T; Kadowaki S; Hasegawa H; Honda S; Netsu S; Ishino M; Arimoto T; Miyashita T; Miyamoto T; Konta T; Kubota I
    Circ Heart Fail; 2013 Jul; 6(4):662-8. PubMed ID: 23674363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Risk of End-Stage Kidney Disease in Patients with Chronic Kidney Disease and Heart Failure with Reduced Ejection Fraction.
    Al-Chalabi S; Poulose M; Rengarajan S; Kalra PR; Green D; Chinnadurai R; Sinha S; Kalra PA
    Cardiorenal Med; 2024; 14(1):397-406. PubMed ID: 38952127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Takahashi H; Kadowaki S; Narumi T; Honda Y; Wanezaki M; Sasaki S; Tamura H; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
    J Cardiol; 2014 Nov; 64(5):353-9. PubMed ID: 24685687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Unger ED; Dubin RF; Deo R; Daruwalla V; Friedman JL; Medina C; Beussink L; Freed BH; Shah SJ
    Eur J Heart Fail; 2016 Jan; 18(1):103-12. PubMed ID: 26635076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction.
    Clemmer JS; Ward TJ; Lirette ST
    ESC Heart Fail; 2023 Jun; 10(3):2010-2018. PubMed ID: 37042079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Savarese G; Xu H; Trevisan M; Dahlström U; Rossignol P; Pitt B; Lund LH; Carrero JJ
    JACC Heart Fail; 2019 Jan; 7(1):65-76. PubMed ID: 30553905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-to-globulin ratio predicts clinical outcomes of heart failure with preserved ejection fraction in women.
    Otaki Y; Shimizu M; Watanabe T; Tachibana S; Sato J; Kobayashi Y; Saito Y; Aono T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
    Heart Vessels; 2022 Nov; 37(11):1829-1840. PubMed ID: 35596031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tubular damage is associated with poor clinical outcome in patients with peripheral artery disease who underwent endovascular therapy.
    Otaki Y; Watanabe T; Takahashi H; Yamaura G; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Int J Cardiol; 2016 Oct; 220():376-81. PubMed ID: 27390958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.